But researchers from Brown University, Rhode Island Hospital and the University of Texas Southwestern Medical Center have discovered that Sirt1 in the brain has its own potential health benefit: It may keep people thinner.
They determined that inhibiting the activity of Sirt1 in the brain's hypothalamic region appears to help control food intake — a finding that potentially lays the groundwork for new treatments for obesity. Details will be published online Dec. 15, 2009, at PLoS ONE.
The discovery is the culmination of the first in-depth study of the metabolic role of Sirt1 in the brain. It suggests that Sirt1 behaves differently in the brain than in organs such as the liver and pancreas, where the enzyme has been more commonly studied.
Sirt1 research so far has posited that fasting activates Sirt1 and thereby helps extend life. Drug companies and scientists have also thrown their support behind resveratrol, a compound found in red wine, thought to be beneficial to the body because it may activate Sirt1. The new Brown research challenges at least some of the preexisting findings, because scientists found that inhibiting the activity of Sirt1 in the brains of rats, rather than stimulating it, appeared to reduce appetite, leading to a smaller weight gain compared to untreated animals. They believe a similar mechanism exists in human brains.
"It's still controversial whether calorie restriction or resveratrol are Sirt1 stimulators," said Eduardo Nillni, the study's lead author. Nillni is professor of medicine (research) at the Warren Alpert Medical School of Brown University and a member of the Department of Molecular Biology, Cell Biology and Biochemistry. At Rhode Island Hospital, Nillni is senior investigator in the Division of Endocrinology. Other authors include researchers from Brown and the University of Texas Southwestern Medical Center.
Nillni's team did find that fasting helped increase Sirt1 production and activity in the brain, consistent with the view that reducing food intake stimulates Sirt1 elsewhere in the body. But they generated clear data showing that pharmacologically or genetically inhibiting Sirt1 activity in the brain led to the animals eating less food and gaining fewer pounds compared to their untreated counterparts.
The study also indentified specific brain receptors or sites where Sirt1 induced food intake — the melanocortin receptors.
Nillni said that more work should be done to investigate whether or how the brain pathways involving Sirt1 and food intake are affected in obese animals.
The National Institutes of Health funded the study.
Editors: Brown University has a fiber link television studio available for domestic and international live and taped interviews, and maintains an ISDN line for radio interviews. For more information, call (401) 863-2476.
Mark Hollmer | EurekAlert!
Speed data for the brain’s navigation system
06.12.2016 | Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)
Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
06.12.2016 | Health and Medicine
06.12.2016 | Life Sciences
05.12.2016 | Power and Electrical Engineering